dence of leukemia relapse. 3 These observations suggest that the graft-versus-leukemia (GVL) effect is associated with the development of GVHD, and alloreactive donor T cells SCID mice were transplanted with H-2-incompatible C3H/He splenocytes with or without previous TBI with may mediate the GVL effect against residual host leukemic cells. 2 Gy to evaluate the influence of sublethal TBI on GVHD and on the graft-versus-leukemia (GVL) effect.
reported that delayed infusion of donor spleen cells after were higher in irradiated mice than those in nonconditioned mice. Cytotoxicity against L1210 cells mediated allogeneic BMT induced the GVL effect without severe acute GVHD after sublethal total body irradiation (TBI). by splenocytes from irradiated recipients was greater than that mediated by effector cells from nonirradiated Xun et al 8 reported that lethal acute GVHD was induced by transplantation of H-2-incompatible splenocytes into severe mice. All the irradiated mice survived more than 120 days after L1210 rechallenge, while all nonirradiated combined immunodeficiency (SCID) mice immediately after TBI using 4 Gy, but none of the mice that received mice died of leukemia within 5 weeks. In conclusion, compared with control mice infused with donor splenodonor splenocytes 4 or 7 days after TBI died of acute GVHD. These experiments showed that sublethal TBI may cytes without previous TBI, SCID mice which received sublethal TBI and DLI showed superior cytotoxicity play an important role in inducing the GVHD and GVL effects. Because SCID mice lack both functional T and B against L1210 cells and survived longer without severe GVHD.
lymphoid systems, they are used to simplify the investigation of the function of transplanted donor immunocytes. Keywords: TBI; GVHD; GVL effect; SCID mouse; DLI We evaluated the GVHD and GVL effects induced by delayed infusion of H-2-incompatible donor spleen cells in irradiated (2 Gy TBI) and nonirradiated SCID mice to investigate the influence of TBI on these effects. The success of allogeneic bone marrow transplantation (BMT) has been threatened by post-transplant complications such as graft-versus-host disease (GVHD) and leuMaterials and methods kemia relapse. Complete donor marrow T cell depletion has been shown to reduce the incidence and severity of GVHD Animals but increase the incidence of relapse and graft failure.
1,2
Furthermore, HLA-identical unrelated BMT has been assoDonor C3H/He (H-2 k ) female mice, 10 to 14 weeks old, ciated with an increased incidence of GVHD but lower inciand 8 to 10-week-old recipient female C.B-17 scid/scid (SCID,H-2 d ) mice were purchased from Charles River Japan, Inc (Shinyokohama, Japan). Animals were housed Correspondence: Dr A Maruta, Department of Hematology/ under specific pathogen-free conditions and were given Chemotherapy, Kanagawa Cancer Centre, 1-1-2, Nakao, Asahi-ku, Yokoautoclaved food and water.
hama-shi, 241, Japan Received 10 January 1997; accepted 21 February 1997 Cell preparations day 4, all animals received 2.5 × 10 7 donor splenocytes. Seven of 10 mice from each group were killed 5 days after Spleens from C3H/He were gently triturated using nylon transplantation to count the T cell subpopulations and to gauze with RPMI-1640 under sterile conditions to obtain a examine the in vitro cytotoxicity against L1210 cells. The single-cell suspension. Prepared cells were resuspended in remaining three mice from each group were rechallenged 0.84% NH 4 Cl to remove erythrocytes, washed twice with with 1 × 10 6 nontreated L1210 cells 2 weeks after the first RPMI-1640, counted, and suspended in PBS for inocutransplantation and their survival was monitored. lation.
Flow cytometry Induction of lethal or sublethal GVHD
Single-cell suspensions of splenocytes and peripheral blood Recipient SCID mice underwent total body irradiation with lymphocytes (PBL) were stained with fluorescein isothio-2 Gy ( 60 Co source) and were infused with 2.5 × 10 7 cyanate (FITC) or the R-phycoerythin (R-PE)-conjugated C3H/He spleen cells 1 h after TBI (TBI/DLI-0, n = 12) or moAbs anti-H-2 k , anti-Thy1.2 (CD90), anti-Lyt 2 (CD8), 5 days after TBI (TBI/DLI-5, n = 12). Control groups were and anti-L3T4 (CD4) (PharMingen, San Diego, CA, USA), either not conditioned before the transplants (TBI(-)/DLI, and were analyzed on a fluorescence-activated cell sorter n = 12) or received 2 Gy TBI without transplantation (FACS) analyzer (Becton Dickinson, San Jose, CA, USA) (TBI/DLI(−), n = 10). Body weights were monitored before using Consort-30 software. and every other day after treatment.
Cytotoxic assay Evaluation of GVL effect
Spleen cells and PBL from the TBI(+) and the TBI(−) SCID mice either did or did not undergo 2 Gy TBI on day groups were used as effector cells. Each cell population −1, and received an intraperitoneal injection of 1 × 10 6 was tested for cytotoxicity and natural killer (NK) activity L1210 cells (H-2   d ; ATCC, Rockville, MD, USA), a murine according to the method described by Toledano et al. 9 Tarlymphoid leukemia cell line, on day 0. Half of the irradiated get YAC-1 cells (ATCC) for NK activity or L1210 cells and nonirradiated animals were infused with 2.5 × 10 A factorial analysis of variance (ANOVA) was used to evaluate the cytokine levels, cytotoxicity, and NK activity.
Histopathology
Survival data were analyzed using Kaplan's method of lifetable analysis. For histopathologic diagnosis of acute GVHD, three mice of each group (TBI/DLI-0, TBI/DLI-5, TBI(−)/DLI, L1210/TBI/DLI, and L1210/TBI(−)/DLI) were killed on days 5 and 7 after donor spleen cell infusion. Control mice Results (TBI/DLI(−), L1210/TBI/DLI(−), and L1210/TBI(−)/ DLI(−)) were also killed on the same days.
Effect of delayed infusion of donor spleen cells on acute GVHD Cytokine assay
All SCID mice, which were conditioned with 2 Gy TBI and Sterile sera were obtained from the animals subjected to infused with C3H/He spleen cells after 1 h (TBI/DLI-0), the GVL induction regimen on day −1 (4 h after TBI), day developed severe diarrhea, showed severe weight loss, and 0 (before L1210 inoculation), day 2, day 4 (before donor died of acute GVHD within 7 days after donor splenocyte splenocyte infusion), day 6, day 9, and day 11, and were infusion. In contrast, mice that received spleen cells 5 days stored immediately at −20°C. Serum tumor necrosis factor after TBI (TBI/DLI-5) developed mild acute GVHD. Two (TNF)-␣, interleukin (IL)-6, IL-2, interferon (IFN)-␥ of the latter mice died of GVHD on day 13 and day 17, (Genzyme, Cambridge, MA, USA), and IL-1␣ (Endogen, respectively, but the survival of the TBI/DLI-5 group was Cambridge, MA, USA) levels were measured using significantly greater than that of the TBI/DLI-0 group ELISA kits.
(P Ͻ 0.01). All mice that received donor spleen cells without any conditioning regimen (TBI(−)/DLI) developed mild GVHD, and all of them survived more than 120 days
Induction of cytolytic T lymphocytes (CTL)
( Figure 1 ). Two of six SCID mice that received TBI without transplantation (TBI/DLI(−)) developed chronic Ten SCID mice were irradiated with 2 Gy and inoculated with 1 × 10 6 L1210 cells which had been pretreated with diarrhea 3 weeks after TBI and died on day 45 and day 67, respectively ( Figure 1 ). mitomycin C (MMC) for 1 h, the next day (TBI(+) group). Another group of 10 nonirradiated mice was also inoculated
The mice in the TBI/DLI-0 group suffered the most severe weight loss. In contrast, the mice in the TBI/DLI-5 and with 1 × 10 6 MMC treated L1210 cells (TBI(−) group). On mice in the TBI/DLI(−) group suffered moderate body weight loss 2 weeks after TBI and never recovered to the normal level (data not shown). ␥. To evaluate cytokine kinetics, serum samples were obtained from SCID mice that underwent GVL induction with or without TBI, and their corresponding control groups (L1210/TBI/DLI, L1210/TBI(−)/DLI, L1210/TBI/DLI(−), Induction of GVL effect in leukemia-bearing mice and L1210/TBI(−)/DLI(−)). During the pretransplantation period (from day −1 to day 4), minor increases in serum Non-transplanted control mice that were inoculated with 1 × 10 6 L1210 cells 1 day after 2 Gy TBI TNF-␣, IL-1␣, and IL-6 were observed in TBI-treated mice but not in nonconditioned mice (Figure 3a , b, c). After (L1210/TBI/DLI(−)) or without TBI (L1210/TBI(−)/ DLI(−)) all died of leukemia within 21 days (Figure 2) . donor splenocyte infusion on day 4, significant increases in serum levels of all cytokines examined were observed in Compared with L1210/TBI/DLI(−) group, the median survival time of mice infused with donor spleen cells 5 days mice from the L1210/TBI/DLI and the L1210/TBI(−)/DLI groups, and these were at maximum on day 9 (5 days postafter TBI (L1210/TBI/DLI) or 4 days after L1210 cell inoculation without TBI (L1210/TBI(−)/DLI) was prodonor spleen cell infusion). All cytokines, except for IFN-␥ (Figure 3e ), showed greater increases in SCID mice from longed by 16 and 13 days, respectively (P Ͻ 0.0001). All mice eventually died of leukemia. The survival time of the the L1210/TBI/DLI group than in those from the L1210/TBI(−)/DLI group. Serum levels of TNF-␣, IL-1␣, mice in the L1210/TBI/DLI group was significantly longer than that of mice in the L1210/TBI(−)/DLI group and IL-6 showed only minor increases in the L1210/TBI/DLI(−) and the L1210/TBI(−)/DLI(−) groups, 1 (P Ͻ 0.01). Mice in the L1210/TBI/DLI and the L1210/TBI(−)/DLI groups developed mild acute GVHD as week after L1210 cell inoculation (Figure 3a, b, c) . In in vitro L1210 cell culture experiments, TNF-␣ and IL-6 revealed by the histopathologic examination, but none of them died of GVHD.
increased in a time-dependent manner in culture mediums, but IL-1␣ was not detected (data not shown). All SCID mice inoculated with L1210 cells died of leukemia with abdominal flatulence and weight gain. Compared with mice in the L1210/TBI(−)/DLI group, those in the L1210/TBI/DLI group gained weight more slowly Effect of TBI on T cell subpopulations and in vitro (P = 0.0009) (data not shown).
cytotoxicity against L1210 target cells mediated by splenocytes and PBL obtained from SCID mice infused with C3H/He spleen cells with or without TBI Effect on cytokine release of donor splenocyte infusion
The T cell subpopulations of splenocytes from mice of the into leukemia-bearing SCID mice after conditioning with TBI(+) group were similar to those of the TBI(−) group.
TBI
The CD8 + cell population was three-fold larger than the CD4 + cell population (Table 1) . But the cytotoxicity of Serum samples from nontreated SCID and C3H/He mice contained no detectable TNF-␣, IL-1␣, IL-6, IL-2, or IFNsplenocytes from SCID mice in the TBI(+) group was Kinetics of serum cytokine levels from leukemia-bearing mice with or without C3H/He spleen cell infusion. Three severe combined immunodeficiency (SCID) mice each were killed on day −1 (4 h after 2 Gy total body irradiation (TBI)), day 0 (before 1 × 10 6 L1210 cell inoculation), day 2 and day 4 (before C3H/He spleen cell infusion); ̅-̅. Non-TBI control mice were also killed on day −1 (normal control), day 0, day 2 and day 4;̆-̆. After day 4, sera were obtained on days 6, 9 and 11, from mice in the L1210/TBI/DLI (n = 3 on each day, ᭺-᭺, the L1210/TBI(−)/DLI (n = 3 on each day, ᭹-᭹), the L1210/TBI/DLI(−) (n = 3 on each day, ٗ-ٗ), and the L1210/TBI(−)/DLI(−) (n = 3 on each day, -) groups.
* P Ͻ 0.0001, ** P Ͻ 0.05 compared with the L1210/TBI/DLI(−) and the L1210/TBI(−)/DLI(−) groups. greater than that of splenocytes from SCID mice in the CD8 positive T cell subpopulation of PBL derived from the TBI(+) group was two-fold larger than that from the TBI(−) group (P = 0.0046) (Figure 4 ). In contrast, there was no significant difference between these groups with regard TBI(−) group (Table 1) . Cytotoxicity against L1210 cells mediated by PBL from the TBI(+) group was also greater to NK activity; 17.1% and 16.8%, respectively (data not shown). The CD4 or CD8 positive T cell subpopulations than that mediated by PBL from the TBI(−) group (6.5% and 3.2%, respectively. P = 0.0051, data not shown). of PBL were similar in both groups, while the CD4 and Severe combined immunodeficiency (SCID) mice were treated with 2 Gy and anti-H2-K k or anti-L3T4 (CD4) and anti-Ly2 (CD8) moAbs. The flutotal body irradiation (TBI), inoculated with 1 × 10 6 mitomycin C (MMC) orescence of 10 000 cells in each group was analyzed by fluorescencepretreated L1210 cells the next day, infused with 2.5 × 10 7 donor splenoactivated cell sorter (FACS) analyzer.
cytes 4 days after L1210 cell inoculation, and rechallenged with 1 × 10
nontreated L1210 cells 2 weeks after the first transplantation (TBI(+) group: ᭺-᭺, n = 3). Control mice were also inoculated with MMC-pretreated L1210 cells without TBI, infused wtih donor splenocytes 4 days after L1210 cell inoculation, and rechallenged with nontreated L1210 cells 2 weeks after the first transplantation (TBI(-) group: ᭹-᭹, n = 3).
Discussion
Mild acute GVHD was observed in SCID mice (H-2 d ) which were infused with allogeneic H-2-incompatible (H-2 k ) splenocytes without TBI in our experiments. In the same donor-recipient combination, lethal acute GVHD was observed when donor splenocytes were infused immediately after 2 Gy TBI, but when donor splenocytes were infused 5 days after TBI, the severity of GVHD was reduced. Xun et al 8 also reported that 4-or 7-day delayed infusions of H-2-incompatible donor splenocytes into SCID mice after 4 Gy TBI reduced the severity of GVHD, and that TBI alone increased serum levels of TNF-␣ and IL-1␣, and increased the serum level of IL-6 at a late stage in the absence of allogeneic transplantation. They deduced that a reciprocal interaction between these cytokines and results, 2 Gy TBI did not induce a significant increase in serum levels of cytokines prior to donor splenocyte infusion in our experiments (Figure 3) . The different doses used for TBI may account for the discrepancy between these results.
Survival time of TBI treated and nontreated mice after
Cytokines generally act locally as paracrine or autocrine L1210 cell rechallenge signals. 12 They may be released in the microenvironment of organs targeted by acute GVHD such as the intestinal All three mice infused with C3H/He spleen cells without TBI died of leukemia within 5 weeks after L1210 rechalmucosa, skin, or liver, without a significant increase of serum levels after 2 Gy TBI, and may prime donor splenolenge; however, three mice infused with C3H/He spleen cells 5 days after TBI survived more than 120 days cytes, potentiating their function. A cytokine 'storm', maximum at 5 days after C3H/He ( Figure 5 ). spleen cell infusion, was confirmed in SCID mice; howinjection with MMC treated L1210 cells before donor spleen cell infusion. ever, the severity of the acute GVHD induced in these aniThe NK activity of SCID mice has been shown to be the mals was mild. The serum level of each inflammatory cytosame as that of other strains of mice, 23 and TBI may have kine, except for INF-␥, was significantly higher in mice influenced the SCID mouse NK activity in our experimental from the L1210/TBI/DLI group, than in mice from the system. Because NK cells of SCID mice can mediate graft L1210/TBI(−)/DLI group (Figure 3) , and a more marked rejection, 24 NK activity is not impaired in SCID mice GVL effect was shown in mice from the former group withinfused with donor spleen cells without TBI, and they have out severe acute GVHD. Serum cytokine, such as TNFthe feasibility to reject transplanted L1210 cells and donor ␣, IL-6, IL-2, IFN-␥, and IL-1␣ elevations associated with splenocytes. But there was no significant difference in sur-GVHD have been reported in many clinical studies and anivival time between nontransplanted SCID mice in the mal experiments.
8,10,13-15 IFN-␥ is one of the key cytokines L1210/TBI/DLI(−) and the L1210/TBI(−)/DLI(−) groups. that induce acute GVHD [16] [17] [18] and also induce proliferation So from these results we speculate that L1210 cell growth and differentiation of cytolytic T cells (CTL). 19 Compared was not affected by the effect of 2 Gy TBI. Otherwise, the with serum cytokine levels from mice in the L1210/TBI(−) suspicion of rejection of donor splenocytes in SCID mice DLI group, the IFN-␥ level from mice in the infused with donor spleen cells without TBI remains. In L1210/TBI/DLI group was relatively lower while other particular, the short survival of mice in the TBI(−) group cytokine levels were higher. The cause of this phenomenon after rechallenge was probably due to the influence of the is unknown. One possibility is that suppression of serum recipient's NK cell activity. However, in vitro cytotoxicity IFN-␥ to a relatively low level results in a more marked of spleen cells and PBL from SCID mice in the TBI(+) GVL effect without severe acute GVHD in the group was significantly greater than that of effector cells L1210/TBI/DLI group. from mice in the TBI(−) group. This observation was made There was no significant difference in the NK activity despite the fact that the NK activity of effector cells from between the TBI(+) and the TBI(−) groups. In contrast, the the former group was equal to that of the latter group. These cytotoxicity of splenocytes and PBL from the TBI(+) group results indicate that 2 Gy TBI may increase the GVL effect against L1210 cells was greater than that of the effector by a direct influence on the recipient's NK cell activity and cells from the TBI(−) group. We therefore deduced that the also by potentiating the cytotoxic T cell function through GVL effect against L1210 cells was mainly induced by release of inflammatory cytokines. donor T cells in this fully major histocompatibility complex
In conclusion, sublethal 2 Gy TBI and 5-day delayed (MHC)-mismatched transplantation model. Truitt et al 20 donor splenocyte infusion induced a GVL effect without demonstrated that GVHD is mainly induced by CD4 + cells, severe acute GVHD in SCID mice. The mechanism of this and the GVL response requires both CD4 + and CD8 + T effect on GVL remains unclear, but it may involve an cells in an MHC-identical, minor histocompatibility antigen influence on recipient's immune system, namely, NK (miHA)-mismatched murine model. But the results of other activity, and that on transplanted donor immunocytes animal experiments of the GVL and GVHD have been through releasing of inflammatory cytokines. varied 21, 22 and these results have suggested that the relative importance of CD4 + and CD8 + T cells in the GVL and GVHD accounts for donor-host and leukemia combi
